AMPKα2 exerts its anti-inflammatory effects through PARP-1 and Bcl-6

Brendan Gongol, Traci Marin, I. Chen Peng, Brian Woo, Marcy Martin, Stephanie King, Wei Sun, David A. Johnson, Shu Chien, John Y.J. Shyy

Research output: Contribution to journalArticlepeer-review

56 Citations (Scopus)


B-cell lymphoma-6 protein (Bcl-6) is a corepressor for inflammatory mediators such as vascular cell adhesion molecule-1 and monocyte chemotactic protein-1 and-3, which function to recruit monocytes to vascular endothelial cells upon inflammation. Poly [ADP ribose] polymerase 1 (PARP-1) is proinflammatory, in part through its binding at the Bcl-6 intron 1 to suppress Bcl-6 expression. We investigated the mechanisms by which PARP-1 dissociates from the Bcl-6 intron 1, ultimately leading to attenuation of endothelial inflammation. Analysis of the PARP-1 primary sequence suggested that phosphorylation of PARP-1 Serine 177 (Ser-177) by AMP-activated protein kinase (AMPK) is responsible for the induction of Bcl-6. Our results show that AMPK activation with treatment of 5-aminoimidazole-4-carboxamide ribonucleotide, metformin, or pulsatile shear stress induces PARP-1 dissociation from the Bcl-6 intron 1, increases Bcl-6 expression, and inhibits expression of inflammatory mediators. Conversely, AMPKα suppression or knockdown produces the opposite effects. The results demonstrate an anti-infamatory pathway linking AMPK, PARP-1, and Bcl-6 in endothelial cells.

Original languageEnglish
Pages (from-to)3161-3166
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Issue number8
Publication statusPublished - 2013 Feb 19

All Science Journal Classification (ASJC) codes

  • General


Dive into the research topics of 'AMPKα2 exerts its anti-inflammatory effects through PARP-1 and Bcl-6'. Together they form a unique fingerprint.

Cite this